Boundless Bio, Inc.
For the period ended Sep 30, 2026. Filed Nov 10, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 10, 2026
BOLD$2.45-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Balance Sheets
(in thousands, except par value data)
| September 30, | December 31, | |
|---|---|---|
| 2026 | 2025 | |
| (unaudited) | ||
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $34,909 | $17,868 |
| Short-term investments | 27,985 | 89,713 |
| Prepaid expenses and other current assets | 700 | 2,030 |
| Total current assets | 63,594 | 109,611 |
| Property and equipment, net | — | 3,216 |
| Right-of-use asset, net | — | 43,659 |
| Restricted cash | — | 560 |
| Other assets | — | 13 |
| Total assets | $63,594 | $157,059 |
| Liabilities and stockholders’ equity | ||
| Current liabilities | ||
| Accounts payable and accrued liabilities | $1,190 | $6,727 |
| Accrued compensation | 682 | 2,643 |
| Lease liabilities, current portion | — | 3,167 |
| Total current liabilities | 1,872 | 12,537 |
| Lease liabilities, non-current | — | 45,868 |
| Total liabilities | 1,872 | 58,405 |
| Commitments and contingencies (Note 8) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 70,000 shares authorized and no shares issued and outstanding as of September 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; 700,000 shares authorized, 23,109 shares issued and outstanding as of September 30, 2026; 700,000 shares authorized, 22,407 shares issued and outstanding as of December 31, 2025 | 2 | 2 |
| Additional paid-in-capital | 364,020 | 358,257 |
| Accumulated other comprehensive income (loss) | (19) | 64 |
| Accumulated deficit | (302,281) | (259,669) |
| Total stockholders’ equity | 61,722 | 98,654 |
| Total liabilities and stockholders’ equity | $63,594 | $157,059 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.